|
|
Article: French Inventor Develops Post-Ischemic Brain Cell Deterioration Treatment Method
- Article from:
- US Fed News Service, Including US State News
- Article date:
- September 20, 2008
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
ALEXANDRIA, Va., Sept. 20 -- Marc Lemaire of Paris has developed a xenon donor.
According to the abstract released by the U.S. Patent & Trademark Office: "A medicinal composition and method to treat or minimize post-ischemic brain cell deterioration that comprises nitrous oxide or a nitrous oxide donor and xenon or a xenon donor. The medicinal composition may be administered prior to or subsequent to a stroke."
The inventor was issued U.S. Patent No. 7,405,241 on July. 29.
The patent has been assigned to Air Liquide Sante, Paris.
The original application was filed on Jan. 15, 2004, and is available at: ...